Announcements Trials
Browse Landscape

Status

Recruiting 1Not yet recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 2

Sponsor

Cancer Type

Other solid neoplasm 2

Conditions

Neoplasms 41Breast Neoplasms 40Lung Neoplasms 25Carcinoma, Non-Small-Cell Lung 20Colorectal Neoplasms 19Uterine Cervical Neoplasms 13Prostatic Neoplasms 13Head and Neck Neoplasms 11Carcinoma, Hepatocellular 11Pancreatic Neoplasms 10Melanoma 10Ovarian Neoplasms 9Neoplastic Cells, Circulating 7Myelodysplastic Syndromes 7Glioma 7Esophageal Neoplasms 7Endometrial Neoplasms 7Brain Neoplasms 7Sarcoma 6Multiple Myeloma 6Gastrointestinal Neoplasms 6Carcinoma, Renal Cell 6Triple Negative Breast Neoplasms 5Neoplasm Metastasis 5Leukemia, Myeloid, Acute 5Disease 5Colonic Neoplasms 5Uveal Melanoma 4Skin Neoplasms 4Neoplasm, Residual 4

Interventions

Injections 6pembrolizumab 5toripalimab 3tislelizumab 3senaparib 3Bevacizumab 3sintilimab 2Technetium 2Specimen Handling 2Nivolumab 2Ipilimumab 2Fluorodeoxyglucose F18 2Carboplatin 2Blood Specimen Collection 2zimberelimab 1tumor-cells apoptosis factor, human 1tazemetostat 1spartalizumab 1sacituzumab govitecan 1rucaparib 1osimertinib 1olaparib 1etoposide phosphate 1enzalutamide 1envafolimab 1cemiplimab 1cedazuridine 1atezolizumab 1WW Domain-Containing Oxidoreductase 1Ultrasonography, Doppler 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Solid Tumor × Blood Specimen Collection × 1 year × Clear all
NCT06895681 2026-05-04

UCSF Biobank for Hereditary Cancers and Tumor-Associated Mutations

University of California, San Francisco

Not yet recruiting
50,000 enrolled
Other solid neoplasm

Solid Tumor

NCT07137312 2025-12-23

Ex Vivo Expansion (ACT-X)

Mayo Clinic

Recruiting
24 enrolled
Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡